Decode Research Team
Neurodegenerative disease research interest in Retatrutide is driven by whether its mechanism engages neuroprotection, neuroinflammation reduction, synaptic plasticity enhancement, protein aggregation inhibition, mitochondrial function, or neurogenesis. Published in vitro and animal model data for Retatrutide should specify which disease models were used (APPswe/PSEN1 for Alzheimer's, MPTP for Parkinson's, SOD1 for ALS), as mechanistic findings may be model-specific and require careful translation consideration.
⚠️ Please note: All peptides offered by Decode Peptides are strictly for research purposes only and are not intended for human consumption, medical treatment, or veterinary use. Always consult a licensed healthcare professional before making any health-related decisions.